Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Edwards Intuity wins FDA nod for “rapid deploy” heart valve trial
Edwards Lifesciences wins an investigational device exemption from the FDA to begin clinical trials of its Edwards Intuity aortic heart valve system with rapid deployment technology.
2. Boston Scientific closes enrollment in Watchman trial
Boston Scientific closes enrollment with more than 2,000 patients in its Prevail trial comparing its Watchman left atrial appendage closure device with the anticoagulant Warfarin.
1. FDA panel: Avoid metal-on-metal hips but don’t panic
Most patients who already have metal-on-metal hip implants will be OK, according to an FDA advisory panel, but orthopedic surgeons should avoid using them from now on.
